Net shares · 365d
-21.3K
0 buy · 21.3K sell
Net value · 365d
-$3.9M
$0 in · $3.9M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
5
0 buy · 21.3K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
DGX Exercise·M
SVP, Clinical Solutions · 10b5-1
$1.0M
8.1K sh · $124.22 avg · 2 lots
Own New
-
DGX Sell·S
SVP, Clinical Solutions · 10b5-1
$1.6M
8.1K sh · $200.00
Own -38%
-
DGX Exercise·M
SVP, Clinical Solutions · 10b5-1
$1.0M
8.1K sh · $124.22 avg · 2 lots
Own +60%
-
DGX Other·L
SVP, Clinical Solutions
$7.6K
39 sh · $194.70
-
DGX Sell·S
SVP, Clinical Solutions
$538.4K
2.6K sh · $204.86
Own -16%
-
DGX Grant·A
SVP, Clinical Solutions
$1.3M
6.2K sh · $204.86
Own +63%
-
DGX Other·F
SVP, Clinical Solutions
$42.0K
205 sh · $204.86
Own -2%
-
DGX Grant·A
SVP, Clinical Solutions
$0
9.9K sh
Own New
-
DGX Grant·A
SVP, Clinical Solutions
$0
2.1K sh
Own +27%
-
DGX Other·F
SVP, Clinical Solutions
$106.5K
511 sh · $208.48 avg · 2 lots
Own -6%
-
DGX Other·L
SVP, Clinical Solutions
$2.9K
16 sh · $183.52
-
DGX Grant·A
SVP, Clinical Solutions
$2.8K
15 sh · $189.08
Own +0%
-
DGX Other·F
SVP, Clinical Solutions
$21.6K
123 sh · $175.91
Own -1%
-
DGX Sell·S
SVP, Clinical Solutions · 10b5-1
$1.8M
10.5K sh · $167.95 avg · 3 lots
Own -55%
-
DGX Exercise·M
SVP, Clinical Solutions · 10b5-1
$849.8K
8.3K sh · $102.77 avg · 2 lots
Own New
-
DGX Exercise·M
SVP, Clinical Solutions · 10b5-1
$849.8K
8.3K sh · $102.77 avg · 2 lots
Own +109%
-
DGX Other·L
SVP, Clinical Solutions
$4.5K
27 sh · $167.50
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | DGX | Exercise M | 8.1K2 lots | $1.0M |
| Jun 4, 2026 | DGX | Sell S | 8.1K | $1.6M |
| Jun 4, 2026 | DGX | Exercise M | 8.1K2 lots | $1.0M |
| Apr 20, 2026 | DGX | Other L | 39 | $7.6K |
| Mar 4, 2026 | DGX | Sell S | 2.6K | $538.4K |
| Mar 4, 2026 | DGX | Grant A | 6.2K | $1.3M |
| Mar 2, 2026 | DGX | Other F | 205 | $42.0K |
| Feb 18, 2026 | DGX | Grant A | 9.9K | $0 |
| Feb 18, 2026 | DGX | Grant A | 2.1K | $0 |
| Feb 18, 2026 | DGX | Other F | 5112 lots | $106.5K |
| Jan 28, 2026 | DGX | Other L | 16 | $2.9K |
| Oct 21, 2025 | DGX | Grant A | 15 | $2.8K |
| Aug 13, 2025 | DGX | Other F | 123 | $21.6K |
| Jul 31, 2025 | DGX | Sell S | 10.5K3 lots | $1.8M |
| Jul 30, 2025 | DGX | Exercise M | 8.3K2 lots | $849.8K |
| Jul 30, 2025 | DGX | Exercise M | 8.3K2 lots | $849.8K |
| Jul 21, 2025 | DGX | Other L | 27 | $4.5K |
Buy Sell Non-market (grant · exercise · gift)
About KUPPUSAMY KARTHIK
This profile aggregates every SEC Form 4 insider transaction reported by KUPPUSAMY KARTHIK across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.